ALX Oncology Announces Initiation Of Phase 2 Investigator-Sponsored Trial Of Neoadjuvant RadiationAand Evorpacept In Combination With Pembrolizumab In Patients With Untreated HPV-Mediated Oropharyngeal Cancer
ALX Oncology宣布启动由研究者赞助的新辅助放射和Evorpacept联合Pembrolizumab治疗未经治疗的HPV介导的口咽癌患者的2期试验